Variant proteins on the surface of malaria-infected erythrocytes--developing vaccines.
Duffy
P E
PE
Malaria Antigen Discovery Program, Seattle Biomedical Research Institute, WA 98109, USA. pduffy@sbri.org
Craig
A G
AG
Baruch
D I
DI
D000818:Animals; D000940:Antigenic Variation / Q000276:immunology; D004910:Erythrocyte Membrane / Q000276:immunology* / Q000378:metabolism / Q000469:parasitology; D005260:Female; D006801:Humans; D017780:Malaria Vaccines / Q000276:immunology* / Q000627:therapeutic use; D016778:Malaria, Falciparum / Q000276:immunology* / Q000517:prevention & control; D010963:Plasmodium falciparum / Q000276:immunology*; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000276:immunology / Q000517:prevention & control; D015800:Protozoan Proteins / Q000276:immunology*
D017780:Malaria Vaccines; D015800:Protozoan Proteins; C085731:erythrocyte membrane protein 1, Plasmodium falciparum